The Uganda Pharma & Healthcare Expo 2026, held from 26th to 28th March 2026 at the UMA Show Grounds in Lugogo, marked the 5th edition of one of East Africa’s leading pharmaceutical and medical exhibitions. The event brought together a wide range of stakeholders across the healthcare value chain, including pharmaceutical manufacturers, medical device companies, healthcare professionals, regulators, and investors from Uganda and several international markets such as India, China, Turkey, and the United Arab Emirates.

Among other benefits, the expo served as a strategic business-to-business (B2B) platform, enabling networking and partnerships between local distributors and global suppliers seeking entry into the Ugandan and broader East African market, and also provided an avenue for distributors and or suppliers to receive direct feedback from users of the products. Given Uganda’s heavy reliance on imported medicines, the exhibition highlighted significant opportunities for investment, local pharmaceutical manufacturing, and supply chain strengthening.

A broad spectrum of sectors was represented, including pharmaceuticals, medical equipment, diagnostics, laboratory technologies, nutraceuticals, and digital health solutions. In addition to product exhibitions, the event facilitated knowledge exchange through discussions on regulatory frameworks, healthcare innovation, and emerging industry trends.

Key local pharmaceutical distributors included but not limited to JMS, ABACUS, MU PHARMA, PISTON PHARMA, SURGIPHARM among others

Mu Pharma Uganda recently welcomed a team from Equity Bank Uganda for a strategic meeting focused on strengthening collaboration and supporting the company’s growing operations.

The visit provided an opportunity for both teams to discuss financial solutions and partnership strategies aimed at enhancing operational efficiency and enabling sustainable growth. As Mu Pharma Uganda continues to expand its role in improving healthcare access, strong financial partnerships remain essential to driving impact.

The engagement reflects a shared commitment to growth, innovation, and building resilient systems that support Uganda’s healthcare sector.

Mu Pharma Uganda appreciates Equity Bank Uganda’s visit and looks forward to a fruitful partnership ahead.

On 12th December 2025, MU Pharma wrapped up the year with a lively End-of-Year Party, bringing the team together to celebrate achievements, teamwork, and shared success.

The evening was filled with energy, appreciation, and memorable moments, reflecting the company’s strong culture and commitment to excellence. Team members celebrated milestones, acknowledged contributions, and strengthened bonds across departments.

As MU Pharma looks ahead, the spirit of gratitude and inspiration continues to drive the company’s mission to deliver innovative, high-quality healthcare solutions across the region.

On 2nd December 2025, Mu Pharma visited Georgina Eye Clinic to celebrate Dr. Juliet Otiti Sengeri and express appreciation for her continued support of Mu Pharma brands.

The visit recognized Dr. Sengeri’s remarkable achievement of earning a PhD from the University of Antwerp, Belgium, reflecting her dedication and excellence in advancing eye health in Uganda and beyond.

The meeting also reinforced Mu Pharma’s commitment to building strong partnerships with healthcare professionals, supporting innovation, and promoting high-quality ophthalmology care.

On 29th November 2025, Mu Pharma conducted a Continuing Medical Education (CME) session with Pediatric Interns at Mulago National Referral Hospital, focusing on the management of common dermatological conditions in pediatric care.

The session was facilitated by Dr. Hannah Mwebaza, who provided practical insights on Elica, Elicasal, and Elica M, highlighting their therapeutic value, safety profile, and appropriate clinical use. The training emphasized real-world application, enabling interns to confidently integrate these treatments into everyday practice.

Participants appreciated the session for its relevance to routine clinical work and acknowledged the effectiveness and trusted safety of the formulations discussed. The engagement also encouraged responsible prescribing to support improved patient outcomes.

This training reflects Mu Pharma’s ongoing commitment to capacity building, continuous professional education, and supporting healthcare professionals with reliable, high-quality solutions that enhance dermatology care.

On 27th November 2025, Mu Pharma conducted a Continuous Medical Education (CME) session at Mulago National Referral Hospital, bringing together Ophthalmologists, Senior House Officers (SHOs), and Ophthalmic Clinical Officers (OCOs).

The session was facilitated by Mr. Samanya Keziron and attended by Mr. John Manigaruhanga, Team Leader – Ophthalmology, and Dr. Ssewankambo Deo, Field Force Supervisor.

The CME focused on creating awareness of Mu Pharma’s ophthalmology products, including Hyfresh Gel and Croma, with emphasis on their clinical application and role in improving patient care.

Participants engaged in discussions on product use and shared practical experiences from clinical practice. Post-session remarks were delivered by Dr. Ntende Jacob, who emphasized the value of continuous medical education in strengthening eye care services.

This initiative aligns with Mu Pharma’s commitment to providing innovative, high-quality, and affordable healthcare solutions while supporting continuous professional development.

On 20th November 2025, Mu Pharma hosted a dinner meeting with Ocular Ophthalmic Officers (OCOs) at Kenlon Hotel, Mengo to discuss new developments in ophthalmology medications, including Hyfresh Gel, Croma, and Xolamol, aimed at enhancing patient care.

The event provided a relaxed setting for knowledge sharing, professional dialogue, and strengthening partnerships. Team members reflected on innovations and their practical applications in clinical practice. A special photo moment captured Mr. John Manigaruhanga, Mu Pharma Ophthalmology Team Leader, with Dr. Nasaba David, Pharmacist at Mengo Hospital Eye Department, symbolizing collaboration and mutual commitment to eye health.

This dinner meeting highlights Mu Pharma’s dedication to supporting healthcare professionals and fostering innovation that improves ophthalmology care in Uganda.

On 19th November 2025, Mu Pharma held an interactive Continuing Medical Education (CME) session with Pediatric Senior House Officers at Mulago National Referral Hospital, focusing on effective management of pediatric dermatological conditions.

The session, led by Dr. Hannah Mwebaza, highlighted Elica (Mometasone Furoate 0.1%), Elica M, and Elicasal, emphasizing their clinical indications, benefits, and safe use in children. Participants engaged in case-based discussions, shared experiences, and explored best practices for prescribing topical corticosteroids and combination therapies.

This training reinforces Mu Pharma’s commitment to empowering healthcare professionals with practical, evidence-based knowledge, improving patient outcomes, and supporting high-quality dermatology care in Uganda.

MU Pharma was proud to join the Uganda Ophthalmology Society (UOS) Annual Congress as a key sponsor during the two-day event held in Mbarara from 6–7 November 2025. This important gathering brought together ophthalmologists, eye-care specialists, researchers, and industry partners from across Uganda to explore new developments in clinical practice and the future of eye health.

Our participation reaffirmed MU Pharma’s commitment to advancing medical education, strengthening professional networks, and supporting evidence-based eye-care across the country. Throughout the congress, our team interacted with professionals from diverse specialties, showcased our ophthalmic product portfolio, and contributed to conversations centered on improving patient outcomes.

As a company rooted in healthcare excellence, we value our strong relationship with the ophthalmology community. MU Pharma remains dedicated to investing in initiatives that promote continuous learning, innovation, and sustainable improvements in healthcare delivery.

In a remarkable show of commitment to advancing eye health across the region, Mu Pharma proudly sponsored a delegation of distinguished ophthalmologists to attend the Middle East Ophthalmology Meeting (MEOM) Congress in Dubai.

This prestigious gathering brought together experts, innovators, and practitioners from across the world — all united by a shared mission: to protect and enhance the gift of sight.

At Mu Pharma, we believe that progress in healthcare begins with people — the brilliant minds and passionate professionals who dedicate their lives to improving patient outcomes. Supporting their growth and participation in such global platforms is part of our broader vision to bridge knowledge, nurture collaboration, and strengthen medical excellence across Africa and the Middle East.

The MEOM Congress provided invaluable opportunities for dialogue, learning, and the exchange of cutting-edge insights in ophthalmology — from groundbreaking surgical innovations to the latest research in eye disease management. By empowering our regional specialists to engage at this level, Mu Pharma continues to champion a future where every patient receives the best possible eye care, guided by global standards and local expertise.

This sponsorship is not just an act of partnership; it’s a reflection of our unwavering purpose — to make quality healthcare accessible, progressive, and impactful.